According to Iyiou, artificial intelligence medical service provider Zhen Health just received a few million dollars in Series A financing. This round of financing was led by GP Capital. The funds will be used to expand physical stores, products R&D and marketing.
Zhen Health was founded in 2015, the company is committed to providing medical institutions with ophthalmic auxiliary treatment solutions. Zhen Health provides solutions for remote reading, remote consultation, remote screening and clinical tools. In addition, Zhen Health launched the world's first portable intelligent fundus camera in November 2018.
According to the "China Adult Diabetes Prevalence and Control Status", the prevalence of diabetes in Chinese adults aged 18 and over has reached 11.6%, and the prevalence of diabetes has reached 50.1%. In most people with diabetes, more than one-third of them develop complications of diabetic retinopathy, and the probability of blindness in patients with glycoprotein disease is very high.
That's why Zhen Health introduced a new product named "intelligent screening fundus camera", In the intelligent classification of fundus images, Zhen Health has achieved an accuracy rate of 96% in tens of millions of images distributed recognition. For the fundus image registration in different periods, the accuracy rate in observing the development of the disease is at 92%, and the products have been clinically tested.
About GP Capital
Shanghai GP Capital is a private equity firm focused on funding financial services companies in China.